Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats

Experimental Neurology

Volumn 239, Issue 1, 2013, Pages 158-162

  Mitkari, Bhimashankar ^a   Kerkelä, Erja ^b   Nystedt, Johanna ^b   Korhonen, Matti ^b   Mikkonen, Ville ^a   Huhtala, Tuulia ^a   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Biodistribution; Cell therapy; Cellular engineering; Cerebral ischemia; Mesenchymal stem cells; SPECT imaging

Indexed keywords

8 QUINOLINOL; CELL MEMBRANE PROTEIN; CELL SURFACE ADHESION PROTEIN; INDIUM 111; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN ISCHEMIA; CELL CULTURE; CELL LABELING; CELLULAR DISTRIBUTION; DISEASE DURATION; EXTERNAL CAROTID ARTERY; HEMISPHERE; ISOTOPE LABELING; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RADIOACTIVITY; RAT; SHAM PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BONE MARROW TRANSPLANTATION; BRAIN; BRAIN ISCHEMIA; CELL DIVISION; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRA-ARTERIAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84868245654     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.09.018     Document Type: Article

References (28)

1. Banerjee S., Williamson D., Habib N., Gordon M., Chataway J. Human stem cell therapy in ischaemic stroke: a review. Age Ageing 2011, 40:7-13.
2. Barbosa da Fonseca L.M., Gutfilen B., Rosado de Castro P.H., Battistella V., Goldenberg R.C., Kasai-Brunswick T., Chagas C.L., Wajnberg E., Maiolino A., Salles Xavier S., Andre C., Mendez-Otero R., de Freitas G.R. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol. 2010, 221:122-128.
3. Bieback K., Hecker A., Kocaömer A., Lannert H., Schallmoser K., Strunk D., Klüter H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009, 27:2331-2341.
4. Bliss T.M., Andres R.H., Steinberg G.K. Optimizing the success of cell transplantation therapy for stroke. Neurobiol. Dis. 2010, 37:275-283.
5. Borlongan C.V., Glover L.E., Tajiri N., Kaneko Y., Freeman T.B. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog. Neurobiol. 2011, 95:213-228.
6. Brenneman M., Sharma S., Harting M., Strong R., Cox C.S., Aronowski J., Grotta J.C., Savitz S.I. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J. Cereb. Blood Flow Metab. 2010, 30:140-149.
7. Chua J.Y., Pendharkar A.V., Wang N., Choi R., Andres R.H., Gaeta X., Zhang J., Moseley M.E., Guzman R. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J. Cereb. Blood Flow Metab. 2011, 31:1263-1271.
8. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
9. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009, 18:683-692.
10. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974, 17:331-340.
11. 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect. Nucl. Med. Commun. 2009, 30:210-216.
12. Hatlapatka T., Moretti P., Lavrentieva A., Hass R., Marquardt N., Jacobs R., Kasper C. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng. Part C, Methods 2011, 17:485-493.
13. Hicks A.U., Lappalainen R.S., Narkilahti S., Suuronen R., Corbett D., Sivenius J., Hovatta O., Jolkkonen J. Transplantation of human embryonic stem cell (hESC)-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur. J. Neurosci. 2009, 29:562-572.
14. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4:206-216.
15. Khalil M.M., Tremoleda J.L., Bayomy T.B., Gsell W. Molecular SPECT imaging: an overview. Int. J. Mol. Imaging 2011, 2011:796025.
16. Lappalainen R., Narkilahti S., Huhtala T., Liimatainen T., Suuronen T., Närvänen A., Suuronen R., Hovatta O., Jolkkonen J. SPECT imaging shows accumulation of stem cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 2008, 440:246-250.
17. Li L., Jiang Q., Ding G., Zhang L., Zhang Z.G., Li Q., Panda S., Lu M., Ewing J.R., Chopp M. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J. Cereb. Blood Flow Metab. 2010, 30:653-662.
18. Lindvall O., Kokaia Z. Stem cell research in stroke: how far from the clinic?. Stroke 2011, 42:2369-2375.
19. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
20. Lundberg J., Söderstenm E., Sundström E., Blanc K.L., Andersson T., Hermanson O., Holmin S. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration - engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 2012, 21:333-343.
21. Mäkinen S., Kekarainen T., Nystedt J., Liimatainen T., Huhtala T., Närvanen A., Laine J., Jolkkonen J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res. 2006, 1123:207-215.
22. Mitkari B., Kerkelä E., Nystedt J., Korhonen M., Huhtala T., Jolkkonen J. Toward a more effective intravascular cell therapy in stroke. Advances in the Treatment of Ischemic Stroke 2012, 141-160. Intech, Croatia. M. Balestrino (Ed.).
23. Pendharkar A.V., Chua J.Y., Andres R.H., Wang N., Gaeta X., Wang H., De A., Choi R., Chen S., Rutt B.K., Gambhir S.S., Guzman R. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010, 41:2064-2070.
24. 2-antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology 2001, 40:597-606.
25. Sarkar D., Zhao W., Gupta A., Loh W.L., Karnik R., Karp J.M. Cell surface engineering of mesenchymal stem cells. Methods Mol. Biol. 2011, 698:505-523.
26. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., Drexler C., Lanzer G., Linkesch W., Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007, 47:1436-1446.
27. Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabelo J., Young R.G., Pittenger M.F., van Zijl P.C.M., Huang J., Bulte J.W.M. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.
28. 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model. Nucl. Med. Biol. 2010, 37:381-388.